Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programming gene and engineered-cell therapies with synthetic biology
Tasuku Kitada, Breanna DiAndreth, Brian Teague, et al.
Science (2018) Vol. 359, Iss. 6376
Open Access | Times Cited: 230

Showing 1-25 of 230 citing articles:

Metabolic modulation of tumours with engineered bacteria for immunotherapy
Fernando P. Canale, Camilla Basso, Gaia Antonini, et al.
Nature (2021) Vol. 598, Iss. 7882, pp. 662-666
Closed Access | Times Cited: 367
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal, Anna Sokolovska, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 316
Organoids by design
Takanori Takebe, James M. Wells
Science (2019) Vol. 364, Iss. 6444, pp. 956-959
Open Access | Times Cited: 312
Microbiome Engineering: Synthetic Biology of Plant-Associated Microbiomes in Sustainable Agriculture
Jing Ke, Bing Wang, Yasuo Yoshikuni
Trends in biotechnology (2020) Vol. 39, Iss. 3, pp. 244-261
Open Access | Times Cited: 261
Engineering the next generation of cell-based therapeutics
Caleb J. Bashor, Isaac B. Hilton, Hozefa S. Bandukwala, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 655-675
Open Access | Times Cited: 256
Synthetic biology 2020–2030: six commercially-available products that are changing our world
Christopher A. Voigt
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 221
Engineering living therapeutics with synthetic biology
Andrés Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 941-960
Closed Access | Times Cited: 214
Design of fast proteolysis-based signaling and logic circuits in mammalian cells
Tina Fink, Jan Lonzarić, Arne Praznik, et al.
Nature Chemical Biology (2018) Vol. 15, Iss. 2, pp. 115-122
Open Access | Times Cited: 179
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Zhaoting Li, Yixin Wang, Yingyue Ding, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 23
Closed Access | Times Cited: 104
Multidimensional control of therapeutic human cell function with synthetic gene circuits
Hui-Shan Li, Divya V. Israni, Keith A. Gagnon, et al.
Science (2022) Vol. 378, Iss. 6625, pp. 1227-1234
Open Access | Times Cited: 98
The sound of silence: Transgene silencing in mammalian cell engineering
Alan Cabrera, Hailey I. Edelstein, Fokion Glykofrydis, et al.
Cell Systems (2022) Vol. 13, Iss. 12, pp. 950-973
Open Access | Times Cited: 88
Game changers in science and technology - now and beyond
Ulrich A. K. Betz, Loukik Arora, R.A. Assal, et al.
Technological Forecasting and Social Change (2023) Vol. 193, pp. 122588-122588
Open Access | Times Cited: 71
Application of stem cells in regeneration medicine
Ye Jin, Shuangyang Li, Qixuan Yu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 57
Control of mammalian gene expression by modulation of polyA signal cleavage at 5′ UTR
Liming Luo, Jocelyn Duen-Ya Jea, Yan Wang, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 9, pp. 1454-1466
Closed Access | Times Cited: 19
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity
Anirudh Sivakumar, Hathaichanok Phuengkham, Hitha Rajesh, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
A multiplexed, electrochemical interface for gene-circuit-based sensors
Peivand Sadat Mousavi, Sarah J. Smith, Jenise B. Chen, et al.
Nature Chemistry (2019) Vol. 12, Iss. 1, pp. 48-55
Open Access | Times Cited: 118
Synthetic Biology Goes Cell-Free
Aidan Tinafar, Katariina Jaenes, Keith Pardee
BMC Biology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 113
Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery
Dewu Lin, Xiaolan Feng, Bingjie Mai, et al.
Biomaterials (2021) Vol. 277, pp. 121124-121124
Closed Access | Times Cited: 94
Enhancing the tropism of bacteria via genetically programmed biosensors
Tiffany Chien, Tetsuhiro Harimoto, Benjamin Kepecs, et al.
Nature Biomedical Engineering (2021) Vol. 6, Iss. 1, pp. 94-104
Open Access | Times Cited: 90
Stem cell bioengineering: building from stem cell biology
Mukul Tewary, Nika Shakiba, Peter W. Zandstra
Nature Reviews Genetics (2018) Vol. 19, Iss. 10, pp. 595-614
Closed Access | Times Cited: 89
Light‐Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic Biology
Maysam Mansouri, Tobias Strittmatter, Martin Fussenegger
Advanced Science (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Theranostic cells: emerging clinical applications of synthetic biology
Monica P. McNerney, Kailyn E. Doiron, Tai L. Ng, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 730-746
Open Access | Times Cited: 84
Engineering advanced cancer therapies with synthetic biology
Ming-Ru Wu, Barbara Jusiak, Timothy K. Lu
Nature reviews. Cancer (2019)
Closed Access | Times Cited: 81
Therapeutic reversal of Huntington’s disease by in vivo self-assembled siRNAs
Li Zhang, Tengteng Wu, Yangyang Shan, et al.
Brain (2021) Vol. 144, Iss. 11, pp. 3421-3435
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top